Schubert & CO Ironwood Pharmaceuticals Inc Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$10.37 - $12.56 $238 - $288	23 Added 45.1%	74 $0
Q4 2022 Jan 31, 2023	SELL	$9.9 - $12.43 $59 - $74	-6 Reduced 10.53%	51 $0
Q3 2022 Oct 21, 2022	SELL	$10.14 - $12.38 $233 - $284	-23 Reduced 28.75%	57 $1,000
Q2 2022 Aug 01, 2022	BUY	$11.05 - $12.72 $651 - $750	59 Added 280.95%	80 $1,000
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $31 - $38	3 Added 16.67%	21 $0
Q4 2021 Jan 28, 2022	BUY	$10.86 - $13.95 $195 - $251	18 New	18 $0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.